<DOC>
	<DOCNO>NCT01862458</DOCNO>
	<brief_summary>The objective study scientifically evaluate new substrate fibrinolysis compare standard tPA . The hypothesis , drive recent prospective trial , tPA may benefit addition DNAse . The primary outcome variable two technique length hospitalization initiation treatment .</brief_summary>
	<brief_title>Empyema Treated With tPA &amp; DNAse</brief_title>
	<detailed_description />
	<mesh_term>Empyema</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Patients le 18 year age require intervention empyema one following : Septation loculation see ultrasound compute tomography Greater 10,000 white blood cell identify pleural tap Immunodeficiency process Secondary diagnosis condition keep hospital beyond empyema Existing contraindication chest tube Documented allergy one study medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>empyema</keyword>
	<keyword>tPA</keyword>
	<keyword>dornase</keyword>
</DOC>